Deloitte GenAI in M&A 2026 Pulse Survey: 500 deal leaders on where generative AI is used across the deal cycle

Deloitte surveyed 500 US PE, portfolio-company and corporate M&A leaders in May 2026: GenAI in M&A has crossed the adoption threshold, use is spreading from diligence into close and integration, full integration remains limited, and human review is the top requirement for trusting GenAI in high-stakes deployments.